About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDPhase 4NCT00566761

Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO

Treatment of macular edema secondary to central retinal vein occlusion is more effective with combined therapy of bevacizumab and triamcinolone than bevacizumab alone.

Lead sponsor: Asociación para Evitar la Ceguera en México•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Asociación para Evitar la Ceguera en México

Comparison of two groups with different treatment with registrations of outcome in BCVA and complications

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Macular edema secondary to central retinal vein occlusion
•BCVA worse than 20/40
•Central macular \>250 mc with OCT

Exclusion Criteria

•Diabetic retinopathy or other retinopathy
•Media opacity that does not allow following
•steroid responder
•diagnosed glaucoma or IOP \> 21 mmHg

Related studies

RECRUITINGPhase 1

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

NCT07425522 · Diabetic Macular Edema

DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.

NCT07308639 · Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO)

RECRUITINGPhase 3

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

NCT07449936 · Diabetic Macular Edema, DME, and more

RECRUITINGEARLY Phase 1

Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients

NCT07362927 · Diabetic Macular Edema (DME)

RECRUITINGPhase 3

CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

NCT07449923 · Diabetic Macular Edema, DME, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 30, 2024Terms

Trial snapshot

StatusTERMINATED

PhasePHASE4

Enrollment10

Start dateJun 2007

Last updatedMay 30, 2024

Condition

Macular Edema Central Retinal Vein Occlusion

Locations shown

Asociacion Para Evitar la Ceguera en Mexico

Mexico City, Coyoacan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 30, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions